I agree that this site is using cookies. You can find further informations here.
X
de Bruijn, Marienke
40  results:
Search for persons X
?
1

Predicting Functional Outcome and Response to Therapy of An..:

Brenner, Juliette ; Bastiaansen, Anna ; de Bruijn, Marienke...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
2

Neuronal antibodies in a prospective, multicenter cohort of..:

de Bruijn, Marienke ; Thijs, Roland ; Majoie, Marian...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
3

Anti-NMDAR encefalitis als oorzaak van epilepsie bij een ze..:

Crijnen, Yvette ; De Bruijn, Marienke ; De Vries, Juna..
Epilepsie, periodiek voor professionals.  17 (2019)  4 - p. 20-23 , 2019
Link: https://doi.org/10.54160..
 
?
4

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, a..:

De Bruijn, Marienke ; Van Sonderen, Agnes ; van Coevorden-Hameete, Marleen...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
5

The Relevance of VGKC-Positivity in the Absence of LGI1 and..:

Sonderen, Agnes ; Schreurs, Marco ; De Bruijn, Marienke...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
6

HLA and KIR genetic association and NK cells in anti-NMDAR ..:

Peris Sempere, Vicente ; Luo, Guo ; Muñiz-Castrillo, Sergio...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
7

Predictive Value of Serum Neurofilament Light Chain Levels ..:

Brenner, Juliette ; Mariotto, Sara ; Bastiaansen, Anna E.M....
Neurology.  100 (2023)  21 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
8

Phase II trial of natalizumab for the treatment of anti-Hu ..:

Bastiaansen, Anna E M ; de Jongste, Adriaan H C ; de Bruijn, Marienke A A M...
Neuro-Oncology Advances.  3 (2021)  1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
9

Antibodies Contributing to Focal Epilepsy Signs and Symptom..:

de Bruijn, Marienke A. A. M. ; Bastiaansen, Anna E. M. ; Mojzisova, Hana...
Annals of Neurology.  89 (2021)  4 - p. 698-710 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, a..:

de Bruijn, Marienke A.A.M. ; van Sonderen, Agnes ; van Coevorden-Hameete, Marleen H....
Neurology.  92 (2019)  19 - p. , 2019
Link: https://doi.org/10.1212/..
 
?
11

The expanded clinical spectrum of anti-GABABR encephalitis ..:

van Coevorden-Hameete, Marleen H ; de Bruijn, Marienke A A M ; de Graaff, Esther...
Brain.  142 (2019)  6 - p. 1631-1643 , 2019
Link: https://doi.org/10.1093/..
 
?
12

Long-term neuropsychological outcome following pediatric an..:

de Bruijn, Marienke A.A.M. ; Aarsen, Femke K. ; van Oosterhout, Marielle P....
Neurology.  90 (2018)  22 - p. , 2018
Link: https://doi.org/10.1212/..
 
?
13

The relevance of VGKC positivity in the absence of LGI1 and..:

van Sonderen, Agnes ; Schreurs, Marco W.J. ; de Bruijn, Marienke A.A.M....
Neurology.  86 (2016)  18 - p. 1692-1699 , 2016
Link: https://doi.org/10.1212/..
 
?
14

Anti-LGI1 encephalitis: Clinical syndrome and long-term fol..:

van Sonderen, Agnes ; Thijs, Roland D. ; Coenders, Elias C....
Neurology.  87 (2016)  14 - p. 1449-1456 , 2016
Link: https://doi.org/10.1212/..
 
?
15

Anti-NMDAR encephalitis and other glutamate and GABA recept..:

, In: Handbook of Clinical Neurology; Autoimmune Neurology,
De Bruijn, Marienke A.A.M. ; Titulaer, Maarten J. - p. 199-217 , 2016
Link: https://doi.org/10.1016/..
 
1-15